Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients-Reference-Cited by-同舟云学术

Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients

Published:2014-03 Issue:3 Volume:9 Page:390-396
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Bovolato Pietro,Casadio Caterina,Billè Andrea,Ardissone Francesco,Santambrogio Luigi,Ratto Giovanni Battista,Garofalo Giuseppe,Bedini Amedeo Vittorio,Garassino Marina,Porcu Luca,Torri Valter,Pastorino Ugo

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. The European mesothelioma epidemic;Peto;Br J Cancer,1999

2. Malignant pleural mesothelioma;Tsao;J Clin Oncol,2009

3. Malignant pleural mesothelioma: a population-based study of survival;Milano;J Thorac Oncol,2010

4. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

5. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients;Sugarbaker;J Thorac Cardiovasc Surg,1999

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Operation on Disease Progression and Survival of Patients With Pleural Mesothelioma;The Annals of Thoracic Surgery;2024-07

2. The Role of Surgery in Pleural Mesothelioma;Cancers;2024-04-28

3. CHST4 Gene as a Potential Predictor of Clinical Outcome in Malignant Pleural Mesothelioma;International Journal of Molecular Sciences;2024-02-14

4. Comprehensive Review of Mesothelioma Cases: From Diagnosis to Therapeutic Strategies;Cureus;2024-01-24

5. Long-Term Survival Analysis of Pleural Mesothelioma Patients Undergoing Surgery: Brief Report From a Tertiary Referral Centre;Clinical Lung Cancer;2024-01